AKLI

AKLI - Akili Inc Stock Price, Fair Value and News

$7.700.00 (0.00%)
Market Closed as of 01 Jul 2024, 04:00 pm ET

AKLI Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

AKLI Price Action

AKLI RSI Chart

AKLI Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

AKLI Valuation

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

AKLI Fundamentals

AKLI Revenue

AKLI Earnings

AKLI Profitability

AKLI Investor Care

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
YearQ1Q2Q3Q4
20241.9M---
2023370.0K420.0K1.0M1.7M
2022487.0K446.0K373.0K323.0K
2021-2.8M1.7M538.0K
2020---3.9M
AKLI
Akili, Inc., a digital medicine company, develops cognitive treatments through game-changing technologies. The company provides EndeavorRx, a computer-based testing for cognitive dysfunction across several neurology and psychiatry indications, including attention-deficit hyperactivity disorder, depressive disorder, autism spectrum disorder, multiple sclerosis, and other neuroinflammatory diseases. It offers selective stimulus management engine mechanism to activate the fronto-parietal cortex area in the brain; body brain trainer for attention, impulsivity, working memory, and goal management; and spatial navigation engine for spatial navigation, memory, and planning and organization. Akili, Inc. was founded in 2011 and is headquartered in Boston, Massachusetts.
 CEO
 WEBSITEakiliinteractive.com
 SECTORHealthcare
 INDUSTRYHealth Information Services
 EMPLOYEES111